Neither dabigatran nor rivaroxaban was linked to increased GI bleeding compared with warfarin

被引：3
|
作者：
Koretz, Ronald L. [1 ]
机构：
[1] Olive View UCLA Med Ctr, Sylmar, CA 91342 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2015年 / 163卷 / 06期
关键词：
ORAL ANTICOAGULANTS; METAANALYSIS;
D O I：
10.7326/ACPJC-2015-163-6-013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleeding
    Arachchillage, Deepa R. J.
    Alavian, Sharon
    Griffin, Jessica
    Gurung, Kamala
    Szydlo, Richard
    Karawitage, Nilanthi
    Laffan, Mike
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (05) : 808 - 816
  • [42] In smokers with COPD, neither varenicline nor bupropion was linked to increased CV or neuropsychiatric risk vs NRT
    Kress, Catherine M.
    Obi, Ngozi U.
    Prochazka, Allan V.
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (06) : JC31 - JC31
  • [43] BLEEDING RISK AMONG JAPANESE NON-VALVULAR ATRIAL FIBRILLATION PATIENTS INITIATED ON APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN IN THE REAL WORLD
    Wang, Feng
    Murata, Tatsunori
    Izumi, Naoko
    Kida, Makoto
    Horblyuk, Ruslan
    Terayama, Yasuo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 443 - 443
  • [44] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN, AND RIVAROXABAN COMPARED TO WARFARIN AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US MEDICARE POPULATION
    Amin, Alpesh
    Keshishian, Allison
    Trocio, Jeffrey
    Le, Hannah
    Dina, Oluwaseyi
    Zhang, Qisu
    Baser, Onur
    Vo, Lien
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 316 - 316
  • [45] Length of Hospital Stay and All-Cause Mortality Among Adults With Atrial Fibrillation Hospitalized for Bleeding During Treatment With Warfarin, Dabigatran, or Rivaroxaban
    Charlton, Blake
    Adeboyeje, Gboyega
    Barron, John J.
    Grady, Deborah
    Shin, Jaekyu
    Redberg, Rita
    CIRCULATION, 2015, 132
  • [46] Risk of major bleeding among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban, or warfarin in the US Medicare population
    Amin, A.
    Keshishian, A.
    Trocio, J.
    Dina, O.
    Le, H.
    Rosenblatt, L.
    Mardekian, J.
    Zhang, Q.
    Baser, O.
    Liu, X.
    Vo, L.
    EUROPEAN HEART JOURNAL, 2017, 38 : 964 - 964
  • [47] Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population
    Amin, Alpesh
    Keshishian, Allison
    Trocio, Jeffrey
    Dina, Oluwaseyi
    Le, Hannah
    Rosenblatt, Lisa
    Liu, Xianchen
    Mardekian, Jack
    Zhang, Qisu
    Baser, Onur
    Lien Vo
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (09) : 1595 - 1604
  • [48] In stable CVD, rivaroxaban plus aspirin reduced CV events and increased bleeding compared with aspirin alone
    Borzak, Steven
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (10) : JC52 - JC52
  • [49] COST-EFFECTIVENESS OF DABIGATRAN COMPARED WITH WARFARIN, APIXABAN, RIVAROXABAN AND LOW MOLECULAR WEIGHT HEPARINS FOR THE TREATMENT AND SECONDARY PREVENTION OF VENOUS THROMBOEMBOLISM IN COLOMBIA
    Rosselli, D.
    Rueda, J. D.
    Wolowacz, S.
    Brockbank, J.
    Abeysinghe, S.
    VALUE IN HEALTH, 2014, 17 (07) : A486 - A486
  • [50] RIGHT VENTRICULAR SYSTOLIC PRESSURE IS A SIGNIFICANT DETERMINANT OF EXCESS BLEEDING IN PEOPLE WITH NONVALVULAR ATRIAL FIBRILLATION TREATED WITH DABIGATRAN AND RIVAROXABAN COMPARED TO APIXABAN
    O'Shea, Michael P.
    Yusuf, Ali
    Chao, Chieh Ju
    Ravi, Srekar N.
    Karikalan, Suganya
    Ashraf, Hasan
    Agasthi, Pradyumna
    Newton, Sam
    Barry, Timothy
    Ayoub, Chadi
    Scott, Robert L.
    Arsanjani, Reza
    El Masry, Hicham Z.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 490 - 490
12345